Data complete?
Evaluation appropriate?
Number of risk factors for poor wound healing and dehiscence
Caution: A qualified health practitioner should verify all results.Keep patient data confidential and comply with all legal requirements.
Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited
Purpose: To identify a patient being treated with bevacizumab who is at risk for poor wound healing or dehiscence.
Specialty: Hematology Oncology, Dermatology
Objective: adverse effects
ICD-10: T45.1,
